Claritev Corporation (CTEV)

US — Healthcare Sector

Peers:

Automate Your Wheel Strategy on CTEV

With Tiblio's Option Bot, you can configure your own wheel strategy including CTEV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

symbol CTEV
Rev/Share 56.9914
Book/Share 0.911
PB 42.1518
Debt/Equity 312.4333
CurrentRatio 1.0242
ROIC -0.1646

MktCap 631157722.0
FreeCF/Share -6.059
PFCF -6.4011
PE -0.5307
Debt/Assets 0.911
DivYield 0
ROE -5.1769

Rating D+
Score 1
Recommendation Strong Sell
P/E Score 1
DCF Score 1
P/B Score 1
D/E Score 1

Recent Analyst Ratings

Type	Ticker	Analyst Firm	Previous Rating	Current Rating	Previous Price Target	Current Price Target	Date
Upgrade	CTEV	Piper Sandler	Neutral	Overweight	--	$44	May 29, 2025

News

Claritev and Burjeel Holdings Finalize Strategic Collaboration, Marks Claritev's Expansion into the Middle East

CTEV
Published: May 22, 2025 by: Business Wire
Sentiment: Neutral

MCLEAN, Va. & ABU DHABI, United Arab Emirates--(BUSINESS WIRE)---- $CTEV #CTEV--Claritev Corporation (“Claritev”) (NYSE: CTEV) and Claims Care Revenue Cycle Management LLC (“Claims Care” or “CCRCM”), a division of Burjeel Holdings (ADX: BURJEEL), are pleased to announce the formalization of their strategic relationship, following the signing of a memorandum of understanding (“MoU”) announced last month. This collaboration aims to revolutionize revenue cycle management (“RCM”) in the Middle East and North Afric.

image for news Claritev and Burjeel Holdings Finalize Strategic Collaboration, Marks Claritev's Expansion into the Middle East

Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates

CTEV
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Negative

Claritev Corporation (CTEV) came out with a quarterly loss of $3.43 per share versus the Zacks Consensus Estimate of a loss of $2.20. This compares to loss of $1.20 per share a year ago.

image for news Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates

Claritev Corporation Reports First Quarter 2025 Results

CTEV
Published: May 08, 2025 by: Business Wire
Sentiment: Neutral

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Reports First Quarter 2025 Results.

image for news Claritev Corporation Reports First Quarter 2025 Results

Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

CTEV
Published: May 06, 2025 by: GlobeNewsWire
Sentiment: Neutral

HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all.

image for news Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

About Claritev Corporation (CTEV)

IPO Date 2020-04-03
Website https://www.claritev.com
Industry Medical - Healthcare Information Services
CEO Mr. Travis S. Dalton
Employees 2700

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.